601567 三星醫療
按盤價 
23.410 -1.250 (-5.069%) | 2025/06 - 中期 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 10.144 | 19.574 | 18.563 | 10.318 | 7.889 |
| 總資產報酬率 ROA (%) | 5.154 | 9.826 | 10.088 | 6.099 | 4.832 |
| 投入資產回報率 ROIC (%) | 6.980 | 12.948 | 13.401 | 8.134 | 6.134 | 邊際利潤分析 |
| 銷售毛利率 (%) | 28.972 | 34.724 | 33.915 | 28.882 | 25.368 |
| 營業利潤率 (%) | 17.333 | 17.706 | 19.808 | 12.666 | 12.121 |
| 息稅前利潤/營業總收入 (%) | 16.138 | 19.391 | 19.657 | 12.499 | 13.315 |
| 淨利潤/營業總收入 (%) | 15.239 | 15.570 | 16.757 | 10.607 | 10.076 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 83.796 | 88.626 | 75.131 | 91.411 | 59.367 |
| 價值變動淨收益/利潤總額(%) | 10.327 | 2.111 | 18.263 | -1.956 | 36.375 |
| 營業外收支淨額/利潤總額(%) | 1.384 | 3.271 | -0.371 | -0.026 | -0.521 | 償債能力分析 |
| 流動比率 (X) | 1.331 | 1.767 | 1.785 | 1.445 | 1.633 |
| 速動比率 (X) | 0.876 | 1.245 | 1.309 | 1.129 | 1.395 |
| 資產負債率 (%) | 46.615 | 49.854 | 48.156 | 40.707 | 39.866 |
| 帶息債務/全部投入資本 (%) | 20.743 | 27.739 | 26.952 | 13.814 | 18.714 |
| 股東權益/帶息債務 (%) | 348.065 | 236.830 | 247.302 | 578.259 | 415.457 |
| 股東權益/負債合計 (%) | 112.248 | 99.010 | 106.234 | 143.897 | 149.727 |
| 利息保障倍數 (X) | -11.220 | 17.848 | -254.951 | -76.566 | 10.590 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 75.767 | 65.085 | 67.655 | 80.780 | 97.126 |
| 存貨周轉天數 (天) | 130.674 | 138.509 | 120.210 | 82.127 | 61.477 |
| 備註： | 即時報價更新時間為 22/08/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
